The medical cannabis sector is currently navigating a daunting obstacle course as it struggles to secure vital funding for critical clinical research.
The aftermath of the COVID-19 pandemic, coupled with complex regulatory barriers, has cast a significant shadow over the industry's efforts to advance ...